NDC 66336-619

Butalbital, Aspirin and Caffeine

Butalbital, Aspirin And Caffeine

Butalbital, Aspirin and Caffeine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Dispensing Solutions, Inc.. The primary component is Butalbital; Aspirin; Caffeine.

Product ID66336-619_9b1cedc1-d578-4e5e-a130-21dca030f666
NDC66336-619
Product TypeHuman Prescription Drug
Proprietary NameButalbital, Aspirin and Caffeine
Generic NameButalbital, Aspirin And Caffeine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1979-06-05
Marketing CategoryANDA / ANDA
Application NumberANDA086162
Labeler NameDispensing Solutions, Inc.
Substance NameBUTALBITAL; ASPIRIN; CAFFEINE
Active Ingredient Strength50 mg/1; mg/1; mg/1
Pharm ClassesBarbiturates [CS],Barbiturate [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE]
DEA ScheduleCIII
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 66336-619-60

60 TABLET in 1 BOTTLE, PLASTIC (66336-619-60)
Marketing Start Date1979-06-05
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 66336-619-30 [66336061930]

Butalbital, Aspirin and Caffeine TABLET
Marketing CategoryANDA
Application NumberANDA086162
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1979-06-05
Inactivation Date2019-10-29

NDC 66336-619-60 [66336061960]

Butalbital, Aspirin and Caffeine TABLET
Marketing CategoryANDA
Application NumberANDA086162
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1979-06-05
Inactivation Date2019-10-29

Drug Details

Active Ingredients

IngredientStrength
BUTALBITAL50 mg/1

OpenFDA Data

SPL SET ID:657e4c4a-e50c-49f7-99b4-32395ec19bd8
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 238135
  • Pharm Class PE
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
  • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
  • NUI Code
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722
  • Pharmacological Class

    • Barbiturates [CS]
    • Barbiturate [EPC]
    • Cyclooxygenase Inhibitors [MoA]
    • Decreased Prostaglandin Production [PE]
    • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
    • Nonsteroidal Anti-inflammatory Drug [EPC]
    • Platelet Aggregation Inhibitor [EPC]
    • Decreased Platelet Aggregation [PE]
    • Central Nervous System Stimulant [EPC]
    • Methylxanthine [EPC]
    • Xanthines [CS]
    • Central Nervous System Stimulation [PE]

    NDC Crossover Matching brand name "Butalbital, Aspirin and Caffeine" or generic name "Butalbital, Aspirin And Caffeine"

    NDCBrand NameGeneric Name
    0143-1785Butalbital, Aspirin and CaffeineButalbital, Aspirin and Caffeine
    21695-354Butalbital, Aspirin and CaffeineButalbital, Aspirin and Caffeine
    42543-098Butalbital, Aspirin and CaffeineButalbital, Aspirin and Caffeine
    52959-370Butalbital, Aspirin and CaffeineButalbital, Aspirin and Caffeine
    66336-619Butalbital, Aspirin and CaffeineButalbital, Aspirin and Caffeine

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.